# Beam Therapeutics Inc.: Form 8-K, filed Jan 19, 2021

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 8-K
- Filed: 2021-01-19
- Accepted by EDGAR: Jan 19, 2021, 06:46 ET
- Period: 2021-01-16
- Accession: 0001193125-21-010753
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000119312521010753/d65346d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000119312521010753/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000119312521010753/d65346d8k.htm

Filed Jan 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-010753. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
